Bearish
Pyxis Oncology, Inc. Files Amended 8-K/A Report for 2026 with SEC – Company Details, Address, and Nasdaq Listing
Pyxis Oncology, Inc. (NASDAQ: PYXS) filed an amended Form 8-K/A report with the SEC, announcing the departure of its CEO, Lara Sullivan, M.D., effecti...